Skip to main content
SpringerLink
Log in

Proliferative Vitreoretinopathy

  • Chapter
  • First Online:
Vitreoretinal Surgery

Abstract

Proliferative vitreoretinopathy (PVR) is a cellular proliferation producing ‘epiretinal membranes’ in rhegmatogenous retinal detachment. Primary RRDs which have been present for weeks or months are likely to develop PVR. At presentation, the rate of PVR in all patients with RRD varies depending on the ease of access to health care; where prompt surgery is available, PVR rates of 5 % are expected; however, where there is delay in receiving surgery, PVR rates are much higher, for example, 53 % in South America (Tseng et al. 2004) and 17.5 % in East Africa (Yorston et al. 2002). Failed surgery increases the risk of postoperative PVR which has been reported in 5 % of RRDs with U tears, 18 % with paravascular tears and 25 % of giant retinal tears (Bonnet et al. 1996).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • (1992) Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol 110(6):780–792

    Google Scholar 

  • Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW (2001) Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology 108(7):1179–1183

    Article  PubMed  CAS  Google Scholar 

  • Barr CC, Lai MY, Lean JS, Linton KL, Trese M, Abrams G, Ryan SJ, Azen SP (1993) Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology 100(11):1629–1635

    PubMed  CAS  Google Scholar 

  • Benson SE, Schlottmann PG, Bunce C, Xing W, Charteris DG (2006) Optical coherence tomography analysis of the macula after vitrectomy surgery for retinal detachment. Ophthalmology 113(7):1179–1183. doi:S0161-6420(06)00118-7[pii],10.1016/j.ophtha.2006.01.039

    Article  PubMed  Google Scholar 

  • Blumenkranz M, Hernandez E, Ophir A, Norton EW (1984) 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 91(2):122–130

    PubMed  CAS  Google Scholar 

  • Bonnet M, Fleury J, Guenoun S, Yaniali A, Dumas C, Hajjar C (1996) Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 234(12):739–743

    Article  PubMed  CAS  Google Scholar 

  • Bourke RD, Cooling RJ (1996) Vascular consequences of retinectomy. Arch Ophthalmol 114(2):155–160

    Article  PubMed  CAS  Google Scholar 

  • Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C (2004) A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology 111(12):2240–2245

    Article  PubMed  Google Scholar 

  • Coll GE, Chang S, Sun J, Wieland MR, Berrocal MH (1995) Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 102(4):630–638

    PubMed  CAS  Google Scholar 

  • Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H (1989) Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 107(8):1147–1151

    Article  PubMed  CAS  Google Scholar 

  • Cox MS, Trese MT, Murphy PL (1986) Silicone oil for advanced proliferative vitreoretinopathy. Ophthalmology 93(5):646–650

    PubMed  CAS  Google Scholar 

  • Cox MS, Azen SP, Barr CC, Linton KL, Diddie KR, Lai MY, Freeman HM, Irvine A (1995) Macular pucker after successful surgery for proliferative vitreoretinopathy. Silicone Study Report 8. Ophthalmology 102(12):1884–1891

    PubMed  CAS  Google Scholar 

  • Diddie KR, Azen SP, Freeman HM, Boone DC, Aaberg TM, Lewis H, Radtke ND, Ryan SJ (1996) Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10. Ophthalmology 103(7):1092–1099

    PubMed  CAS  Google Scholar 

  • Duquesne N, Bonnet M, Adeleine P (1996) Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 234(11):677–682

    Article  PubMed  CAS  Google Scholar 

  • Fisher YL, Shakin JL, Slakter JS, Sorenson JA, Shafer DM (1988) Perfluoropropane gas, modified panretinal photocoagulation, and vitrectomy in the management of severe proliferative vitreoretinopathy. Arch Ophthalmol 106(9):1255–1260

    Article  PubMed  CAS  Google Scholar 

  • Glaser BM, Cardin A, Biscoe B (1987) Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology 94(4):327–332

    PubMed  CAS  Google Scholar 

  • Glaser BM, Vidaurri-Leal J, Michels RG, Campochiaro PA (1993) Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology 100(4):466–470

    PubMed  CAS  Google Scholar 

  • Han DP, Rychwalski PJ, Mieler WF, Abrams GW (1994) Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection. Am J Ophthalmol 118(1):24–32

    PubMed  CAS  Google Scholar 

  • Iverson DA, Ward TG, Blumenkranz MS (1990) Indications and results of relaxing retinotomy. Ophthalmology 97(10):1298–1304

    PubMed  CAS  Google Scholar 

  • Kon CH, Asaria RH, Occleston NL, Khaw PT, Aylward GW (2000) Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol 84(5):506–511

    Article  PubMed  CAS  Google Scholar 

  • Lam RF, Cheung BT, Yuen CY, Wong D, Lam DS, Lai WW (2008) Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis. Am J Ophthalmol 145(3):527–533. doi:S0002-9394(07)00922-1[pii],10.1016/j.ajo.2007.10.015

    Article  PubMed  Google Scholar 

  • Lewis H, Aaberg TM (1991) Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. Am J Ophthalmol 111(1):15–19

    PubMed  CAS  Google Scholar 

  • Lewis H, Verdaguer JI (1996) Surgical treatment for chronic hypotony and anterior proliferative vitreoretinopathy. Am J Ophthalmol 122(2):228–235

    PubMed  CAS  Google Scholar 

  • Lewis H, Aaberg TM, Abrams GW, McDonald HR, Williams GA, Mieler WF (1989) Subretinal membranes in proliferative vitreoretinopathy. Ophthalmology 96(9):1403–1414

    PubMed  CAS  Google Scholar 

  • Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112(2):159–165

    PubMed  CAS  Google Scholar 

  • Moisseiev J, Glaser BM (1989) New and previously unidentified retinal breaks in eyes with recurrent retinal detachment with proliferative vitreoretinopathy. Arch Ophthalmol 107(8):1152–1154

    Article  PubMed  CAS  Google Scholar 

  • O’Connell SR, Majji AB, Humayun MS, De Juan E Jr (2000) The surgical management of hypotony. Ophthalmology 107(2):318–323

    Article  PubMed  Google Scholar 

  • Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE, Schwartz SD (2006) Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology 113(11):2041-2047. doi:S0161-6420(06)00725-1[pii]10.1016/j.ophtha.2006.05.039

    Article  PubMed  CAS  Google Scholar 

  • Schwartz SD, Kreiger AE (1998) Proliferative vitreoretinopathy: a natural history of the fellow eye. Ophthalmology 105(5):785–788

    Article  PubMed  CAS  Google Scholar 

  • Scott IU, Flynn HW, Lai M, Chang S, Azen SP (2000) First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am J Ophthalmol 130(6):745–750

    Article  PubMed  CAS  Google Scholar 

  • Scott IU, Flynn HW Jr, Murray TG, Feuer WJ (2003) Outcomes of surgery for retinal detachment associated with proliferative ­vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol 136(3):454–463

    Article  PubMed  Google Scholar 

  • Stappler T, Williams R, Wong D (2010) F4H5: a novel substance for the removal of silicone oil from intraocular lenses. Br J Ophthalmol 94(3):364–367. doi:bjo.2009.161489[pii],10.1136/bjo.2009.161489

    Article  PubMed  Google Scholar 

  • Stern WH, Lewis GP, Erickson PA, Guerin CJ, Anderson DH, Fisher SK, O’Donnell JJ (1983) Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol 96(1):33–42

    PubMed  CAS  Google Scholar 

  • Stolba U, Binder S, Velikay M, Datlinger P, Wedrich A (1995) Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications. Br J Ophthalmol 79(12):1106–1110

    Article  PubMed  CAS  Google Scholar 

  • Tseng W, Cortez RT, Ramirez G, Stinnett S, Jaffe GJ (2004) Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. Am J Ophthalmol 137(6):1105–1115

    Article  PubMed  Google Scholar 

  • Vidaurri-Leal J, de Bustros S, Michels RG (1984) Surgical treatment of giant retinal tears with inverted posterior retinal flaps. Am J Ophthalmol 98(4):463–466

    Article  PubMed  CAS  Google Scholar 

  • Wiedemann P, Hilgers RD, Bauer P, Heimann K (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 126(4):550–559

    Article  PubMed  CAS  Google Scholar 

  • Yorston DB, Wood ML, Gilbert C (2002) Retinal detachment in East Africa. Ophthalmology 109(12):2279–2283

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, St. Thomas’ Hospital, London, UK

    Thomas H. Williamson

Authors
  1. Thomas H. Williamson
    View author publications

    You can also search for this author in PubMed Google Scholar

8.1 Electronic Supplementary material

Below is the link to the electronic supplementary material.

RRD (651,259 KB)

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Williamson, T.H. (2013). Proliferative Vitreoretinopathy. In: Vitreoretinal Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31872-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-31872-6_8

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-31871-9

  • Online ISBN: 978-3-642-31872-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation